Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines

首次发布于 2010 年 6 月 29 日

Telomere and Telomerase

首次发布于 2010 年 8 月 6 日

Rosuvastatin Effect on Telomere-telomerase System in ACS

计划入组 400 人 · 首次发布于 2014 年 11 月 24 日

mRNA-1083

mRNA-1195

telomerase inhibitor (oral solution, cancer)

Moderna, Inc.

United States

BioNTech SE

Germany

Eterna Therapeutics

United States

Rznomics RNA Therapy Shows 23% Complete Response Rate in Liver Cancer Trial

Korean Biotech Companies to Showcase Next-Generation Cancer Therapies at AACR 2026

MAIA Biotechnology's Shares Surge Following FDA Approval of Telomerase Inhibitor